Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019: a systematic review and network meta-analysis combining 66 trials

BACKGROUND: The global pandemic coronavirus disease 2019 (COVID-19) has become a major public health problem and presents an unprecedented challenge. However, no specific drugs were currently proven. This study aimed to evaluate the comparative efficacy and safety of pharmacological interventions in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shan-Shan, Zhou, Qing-Xin, Zeng, Xue-Yang, Zhang, Jing-Xue, Yang, Zhi-Rong, Yang, Qing-Qing, Zhang, Zi-Lu, Chen, Ya-Hong, Sun, Feng, Zhan, Si-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382475/
https://www.ncbi.nlm.nih.gov/pubmed/34320566
http://dx.doi.org/10.1097/CM9.0000000000001672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382475/
https://www.ncbi.nlm.nih.gov/pubmed/34320566
http://dx.doi.org/10.1097/CM9.0000000000001672

Ejemplares similares